Kerecis ehf - Medical Equipment - Deals and Alliances Profile
November 2018
20
About the Report
About the Report
Summary
Kerecis ehf (Kerecis) is a medical device company that provides products that treats chronic wounds and damaged tissue. The company's flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura mater repair, breast reconstruction and abdominal wall reconstruction and for surgical stapling. It also develops mOmega3 fatty acid (fish-sourced fatty acids) technology for use in several dermatological indications such as psoriasis, eczema, dermatitis, keratosis pilaris and pseudofolliculitis. Kerecis also provides fish-skin acellular dermal matrix products including Omega3 Wound, Omega3 Dura, Omega3 Hernia, Omega3 Pectus, Omega3 Seal, and topical creams including Smooth with mOmega3, Footguard with mOmega3, Psoria with mOmega3 and Xma with mOmega3. The company uses complete acellular fish skin for tissue regeneration by transplantation. It operates through its offices in Isafjordur and Reykjavik, Iceland. Kerecis is headquartered in Isafjordur, Iceland.
Kerecis ehf-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Kerecis ehf, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kerecis ehf, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kerecis ehf, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kerecis ehf, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kerecis ehf, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Kerecis ehf, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kerecis ehf, Medical Equipment, Deal Details 10
Venture Financing 10
Kerecis Raises USD1.5 Million in Venture Financing 10
Kerecis Raises USD0.1 Million in Venture Financing 11
Kerecis Raises USD 2 Million In Series A3 Financing 12
Kerecis Raises USD 1 Million In A2 Financing 14
Partnerships 15
Kerecis Enters Into Distribution Agreement With Medline Industries For MariGen Omega3 Regenerative Technology 15
Kerecis ehf-Key Competitors 16
Kerecis ehf-Key Employees 17
Kerecis ehf-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Nov 06, 2017: Kerecis Expands Scientific Advisory Board 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List of Figure
List of Figures
Kerecis ehf, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Kerecis ehf, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Kerecis ehf, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Kerecis ehf, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Kerecis ehf, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kerecis ehf, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Kerecis ehf, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kerecis ehf, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Kerecis ehf, Medical Equipment, Key Facts 2
Kerecis ehf, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Kerecis ehf, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kerecis ehf, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kerecis ehf, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kerecis ehf, Deals By Market, 2012 to YTD 2018 8
Kerecis ehf, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kerecis Raises USD1.5 Million in Venture Financing 10
Kerecis Raises USD0.1 Million in Venture Financing 11
Kerecis Raises USD 2 Million In Series A3 Financing 12
Kerecis Raises USD 1 Million In A2 Financing 14
Kerecis Enters Into Distribution Agreement With Medline Industries For MariGen Omega3 Regenerative Technology 15
Kerecis ehf, Key Competitors 16
Kerecis ehf, Key Employees 17
Kerecis ehf, Other Locations 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.